ArticleBMC geriatrics2026
Factors associated with angiotensin II stimulating vs. inhibiting antihypertensive drug use in older adults.
Article in BMC geriatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundLimited understanding exists regarding factors associated with use of angiotensin II–inhibiting drugs (AIDs) vs. angiotensin II–stimulating drugs (ASDs), antihypertensive treatments increasingly studied for potential neuroprotective effects. This study utilised both survey and claims data to examine factors associated with ASD vs. AID use.
methodsThis retrospective cohort study was conducted with data from Health and Retirement Study (HRS) participants aged ≥ 65 years who had hypertension and consented to link their Medicare data from 2006 to 2020. Modified Poisson regression models were used to analyse factors associated with use of ASDs, AIDs, or a mix of both drugs.
resultsOf 4624 identified HRS-Medicare participants, 23.8% used ASDs, 38.6% used AIDs, and 37.6% had mixed use of ASDs and AIDs. Patients with ASD use (vs. AID use) and patients with mixed use (vs. AID use) were more likely to be female and Black, and were less likely to have heart conditions. Other factors associated with ASD use (vs. AID use) included having a household income >$50 000 USD and being less likely to have any hospitalisation, or emergency department visit. Other unique factors associated with mixed use (vs. AID use) included being obese or overweight, undergoing cholesterol screening, experiencing stroke, receiving ≥ 5 medications other than the studied CNS drugs, and having no use of anticholinergic drugs.
conclusionThis retrospective cohort study of older adults aged ≥ 65 years found several individual-level factors associated with the use of ASDs and mixed use of ASDs and AIDs, compared with AID use only. Our findings highlight the importance of accounting for these factors in investigations of neuroprotective outcomes related to the use of antihypertensive drugs.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.